Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 28 min ago
Peer-reviewedCC BYBiology

Mucin Increases the Virulence of Enterotoxigenic Escherichia coli.

  1. 1Center for Microbial Ecology and Technology (CMET), Department of Biotechnology, Ghent University, Frieda Saeysstraat 1, 9052 Ghent, Belgium.
  2. 2Laboratory of Agrozoology, Department of Plants and Crops, Ghent University, 9000 Ghent, Belgium.

Abstract

Enterotoxigenic Escherichia coli (ETEC) is an important pathogen of humans and other mammals (such as piglets and calves). Mucin, a glycoprotein that forms the major fraction of the intestinal mucus layer, is a key host substance that ETEC encounters in the host environment. This study investigated whether physiologically relevant concentrations of mucin modulate virulence-related phenotypes in ETEC. Growth of ETEC remained unaffected across mucin concentrations ranging from 50 mg/L to 1000 mg/L. Mucin increased swimming motility in a concentration-dependent manner, with motility doubling at the highest concentrations tested relative to the mucin-free control. Further, mucin also increased biofilm formation in a dose-dependent manner, with approximately 4.5-fold higher biofilm levels at the highest concentration. Finally, mucin increased the virulence of ETEC in the invertebrate infection model Galleria mellonella, resulting in a 1.5- to 3.3-fold increase in larval mortality caused by mucin-treated ETEC compared with the untreated ETEC group. These findings indicate that ETEC responds to mucin as a host-derived cue, promoting virulence-associated traits linked to colonization and infection. Understanding this host-pathogen interaction may lead to the development of novel control strategies against ETEC, which is an urgent societal challenge in the context of rising antibiotic resistance.

Related

  1. Enterotoxigenic Escherichia coli hyperimmune bovine colostrum for preventing travellers’ diarrhoea (TD): a randomised, double-blind, placebo-controlled trial
    Tahaniyat Lalani, Nathanial K. Copeland, Jerry Q. Barton +14
    EClinicalMedicinePeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCCrossref
  2. Clinical Distribution and Virulence Gene Profiles of CNF1- and CNF2-Positive Escherichia coli in Calves
    Michał Bednarski, Robert Kupczyński
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Endocrinology & metabolismCrossref
  3. The arginine repressor ArgR controls virulence factors of adherent-invasive Escherichia coli strains
    Queralt Bonet-Rossinyol, Margarita Martinez-Medina, Llorenç Fernández-Coll
    Frontiers in Cellular and Infection MicrobiologyPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismPMCEurope PMC
  4. Resistance, virulence, and population genomic structure of avian pathogenic Escherichia coli from poultry airsacculitis in South Africa.
    Zhuohao Wang, Naima Ameris Guthauser, David Gerber +1
    Poultry sciencePeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  5. Temporal Comparison of Virulence-Associated Characteristics and Metabolic Activity in Fluoroquinolone-Resistant Escherichia coli O25 ST131 Urinary Isolates from Croatia.
    Jasmina Vraneš, Maja Anušić, Vladimira Tičić +4
    Pathogens (Basel, Switzerland)Peer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
BibTeX
@article{meo2026mucin,
  title = {{Mucin Increases the Virulence of Enterotoxigenic Escherichia coli.}},
  author = {Sofia Razzaq Meo and Adithi Ravikumar and Christophe Noppe and Patrick De Clercq and Tom Defoirdt},
  journal = {Biology},
  year = {2026},
  month = oct,
  doi = {10.3390/biology15191722},
  url = {https://europepmc.org/article/MED/42883395},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Mucin Increases the Virulence of Enterotoxigenic Escherichia coli.
AU  - Sofia Razzaq Meo
AU  - Adithi Ravikumar
AU  - Christophe Noppe
AU  - Patrick De Clercq
AU  - Tom Defoirdt
PY  - 2026
DA  - 2026/10/01
JO  - Biology
DO  - 10.3390/biology15191722
UR  - https://europepmc.org/article/MED/42883395
AB  - Enterotoxigenic Escherichia coli (ETEC) is an important pathogen of humans and other mammals (such as piglets and calves). Mucin, a glycoprotein that forms the major fraction of the intestinal mucus layer, is a key host substance that ETEC encounters in the host environment. This study investigated whether physiologically relevant concentrations of mucin modulate virulence-related phenotypes in ETEC. Growth of ETEC remained unaffected across mucin concentrations ranging from 50 mg/L to 1000 mg/L. Mucin increased swimming motility in a concentration-dependent manner, with motility doubling at the highest concentrations tested relative to the mucin-free control. Further, mucin also increased biofilm formation in a dose-dependent manner, with approximately 4.5-fold higher biofilm levels at the highest concentration. Finally, mucin increased the virulence of ETEC in the invertebrate infection model Galleria mellonella, resulting in a 1.5- to 3.3-fold increase in larval mortality caused by mucin-treated ETEC compared with the untreated ETEC group. These findings indicate that ETEC responds to mucin as a host-derived cue, promoting virulence-associated traits linked to colonization and infection. Understanding this host-pathogen interaction may lead to the development of novel control strategies against ETEC, which is an urgent societal challenge in the context of rising antibiotic resistance.
SN  - 2079-7737
ER  -